Home-based care of low-risk febrile neutropenia in children—an implementation study in a tertiary paediatric hospital
- 1 August 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 29 (3), 1609-1617
- https://doi.org/10.1007/s00520-020-05654-z
Abstract
Background Home-based management of low-risk febrile neutropenia (FN) is safe, improves quality of life and reduces healthcare expenditure. A formal low-risk paediatric program has not been implemented in Australia. We aimed to describe the implementation process and evaluate the clinical impact. Method This prospective study incorporated three phases: implementation, intervention and evaluation. A low-risk FN implementation toolkit was developed, including a care-pathway, patient information, home-based assessment and educational resources. The program had executive-level endorsement, a multidisciplinary committee and a nurse specialist. Children with cancer and low-risk FN were eligible to be transferred home with a nurse visiting daily after an overnight period of observation for intravenous antibiotics. Low-risk patients were identified using a validated decision rule, and suitability for home-based care was determined using disease, chemotherapy and patient-level criteria. Plan-Do-Study-Act methodology was used to evaluate clinical impact and safety. Results Over 18 months, 292 children with FN were screened: 132 (45%) were low-risk and 63 (22%) were transferred to home-based care. Compared with pre-implementation there was a significant reduction in in-hospital median LOS (4.0 to 1.5 days, p < 0.001) and 291 in-hospital bed days were saved. Eight (13%) patients needed readmission and there were no adverse outcomes. A key barrier was timely screening of all patients and program improvements, including utilising the electronic medical record for patient identification, are planned. Conclusion This program significantly reduces in-hospital LOS for children with low-risk FN. Ongoing evaluation will inform sustainability, identify areas for improvement and support national scale-up of the program.Funding Information
- National Health and Medical Research Council (APP1104527)
- Better Care Victoria
This publication has 30 references indexed in Scilit:
- Management of fever and neutropenia in children with cancer: A survey of Australian and New Zealand practiceJournal of Paediatrics and Child Health, 2018
- Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 UpdateJournal of Clinical Oncology, 2017
- Risk‐stratification management of febrile neutropenia in pediatric hematology‐oncology patients: Results of a French nationwide surveyPediatric Blood & Cancer, 2016
- Variation in practice remains in the UK management of paediatric febrile neutropeniaArchives of Disease in Childhood, 2016
- Systematic review of reduced therapy regimens for children with low risk febrile neutropeniaSupportive Care in Cancer, 2016
- Variation in Management of Fever and Neutropenia Among Pediatric Patients With Cancer: A Survey of Providers in MichiganPediatric Hematology and Oncology, 2015
- Guideline for the Management of Fever and Neutropenia in Children With Cancer and/or Undergoing Hematopoietic Stem-Cell TransplantationJournal of Clinical Oncology, 2012
- Updated Systematic Review and Meta-Analysis of the Performance of Risk Prediction Rules in Children and Young People with Febrile NeutropeniaPLOS ONE, 2012
- Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children—a systematic review of prospective trialsSupportive Care in Cancer, 2012
- Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young peopleEuropean Journal of Cancer, 2010